| Literature DB >> 27569765 |
Annabelle Biscans1, Jean-Rémi Bertrand2, Josephine Dubois3, Jacqueline Rüger3, Jean-Jacques Vasseur1, Georg Sczakiel4, Christelle Dupouy1, Françoise Debart5.
Abstract
The in vivo application of siRNA depends on its cellular uptake and intracellular release, and this is an unsatisfactorily resolved technical hurdle in medicinal applications. Promising concepts directed towards providing efficient cellular and intracellular delivery include lipophilic chemical modification of siRNA. Here we describe chemistry for the production of modified siRNAs designed to display improved transmembrane transport into human cells while preserving the potency of the RNAi-based inhibitors. We report the synthesis and the biochemical and biophysical characteristics of 2'-O-phenylisobutyryloxymethyl (PiBuOM)-modified siRNAs and their impact on biological activity. In the case of spontaneous cellular uptake of naked PiBuOM-modified siRNA, we observed increased target suppression in human cells relative to unmodified or pivaloyloxymethyl (PivOM)-modified siRNA. We provide evidence of improved spontaneous cellular uptake of naked PiBuOM-modified siRNA and of substantial target suppression in human cells in serum-containing medium.Entities:
Keywords: RNA; acetal ester modifications; cellular uptake; lipophilicity; siRNA
Mesh:
Substances:
Year: 2016 PMID: 27569765 DOI: 10.1002/cbic.201600317
Source DB: PubMed Journal: Chembiochem ISSN: 1439-4227 Impact factor: 3.164